Search Index Entries

2178 Results
TitlePublication
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19Nature Communications
SARS-CoV-2 Is an Unrestricted Bioweapon: A Truth Revealed through Uncovering a Large-Scale, Organized Scientific FraudZenodo
SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048) — 2.6.4 Summary statement of the pharmacokinetic study
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levelsPLOS One
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In VitroInternational Journal of Molecular Sciences
SARS-CoV-2 re-infection risk in AustriaEuropean Journal of Clinical Investigation
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like Symptoms
SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 MicrogliaMolecular Neurobiology
SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccinationJournal of Pathology, Microbiology and Immunology
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
SARS-CoV-2 spike protein alone may cause lung damageMedical Xpress
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic CellsCells
SARS-CoV-2 Spike Protein and Lung Vascular CellsJournal of Respiration
SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfateInternational Journal of Biological Macromolecules
SARS-CoV-2 Spike Protein Disrupts Blood–Brain Barrier Integrity via RhoA ActivationJournal of Neuroimmune Pharmacology
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 VaccinesVaccines journal
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2Circulation Research
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy
SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal deathScientific Reports
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier IntegrityFrontiers in Cardiovascular Medicine
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegenerationBiochemical and Biophysical Research Communications
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19Bioscience Reports
SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathyCell Discovery
SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assemblyJournal of Experimental Medicine
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapiesInfection
SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells
SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human MicrogliaFrontiers in Immunology
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signalingNature Communications
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopeniaBlood Advances
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million ResidentsJAMA Cardiology
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of OncogenesisCureus
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitisJournal of Hepatology
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic ComplicationAnnual Review of Medicine
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan
SARS-CoV-2 Vaccine Breakthrough Surveillance and Case Information Resource
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021Science
SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 20
SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 23
SARS-CoV-2 Virus Real-Time PCR
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNature
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cellsNature Communications
SARS-CoV2 spike protein pathogenicity research collectionZenodo
SARS-CoV2 vaccine and viral variant research library
SARS-like WIV1-CoV poised for human emergencePNAS (Proceedings of the National Academy of Sciences)
School children’s mental health during the COVID-19 pandemicFrontiers in Psychology